Arecor Company
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Industry:
PharmTech
Headquarters:
Little Chesterford, Essex, United Kingdom
Zip:
1-10
Founded Date:
2007-01-01
Employees Number:
1-10
Funding Status:
IPO
Acquisitions Number:
17
Investors Number:
34815243
Total Funding:
$1M to $10M
Estimated Revenue:
2021-06-03
Last Funding Date:
Post-IPO Equity
Last Funding Type:
info@arecor.com
Register and Claim Ownership